Registered entities
FoRx Therapeutics AG
Reg. No. 1410790Switzerland
Innovation
19 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 859 times.
| Year | Filings |
|---|---|
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 10 |
| 2026 | 6 |
Social engagement
Social engagement: 7K social following, 4 posts in the last 12 months — below the industry typical range.
Investor mix
7 investors on record; lead investors include Novartis Venture Fund, Omega Funds, M Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Private equity | 2 | 29% |
| Other / undisclosed | 1 | 14% |
Recent activity
22 Jun 2026
Event
BIO International Convention
29 Apr 2026
Event
Swiss Biotech Day
14 Apr 2026
Event
AACR Annual Meeting poster presentation on FORX-428